论文部分内容阅读
中国第三届专利技术博览会上,山西省永济市河东乙肝研究所研制的治疗乙肝、内肝、肝硬化的药物“澳必阴”,荣获本届博览会唯一的一块金牌,把它授予这些在肝病冶疗土地上辛勤耕耘的科研人当之无愧。 澳门针织有限公司董事长李志显患乙肝8年,在美国、日本等地治疗,耗资10万美元,病情不但未减轻,而且还转为肝硬化。去年来大陆旅游期间,他在山西永济市河东乙肝研究所使用所长邵鸣研制的“澳必阴”系列药物,3个疗程后,病体痊愈。因而逢人便说:“没有邵所长就
At the Third Patent Technology Exposition in China, the drug “Opposite-Yin” for the treatment of hepatitis B, liver and liver cirrhosis developed by the Hedong Institute of Hepatology, Yongji City, Shanxi Province won the only gold medal in this exposition and granted it to them Liver disease treatment of hard-working scientists on the land well-deserved. Li Zhi, chairman of Macau Knitting Co., Ltd., was suffering from hepatitis B for eight years and was treated in the United States and Japan at a cost of 100,000 U.S. dollars. His condition was not only relieved but also cirrhosis. During his visit to the mainland last year, he used the “O-Pinyin” series of drugs developed by director Shao Ming at Hedong Hepatitis B Research Institute in Yongji City, Shanxi Province. After three courses of treatment, the patient recovered. So everyone will say: "There is no director Shao